What is Adicet Bio Inc Annual Net Profit?

Adicet Bio Inc Annual Net Profit rose 17.9% in the last year to $117.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

What is Adicet Bio Inc Price to Earning Ratio?

Adicet Bio Inc Price to Earning Ratio is -0.54, which is negative.

What is Adicet Bio Inc Stock Price?

Adicet Bio Inc Stock Price fell 64.84% and underperformed its sector by 73.91% in the past year.

What is Adicet Bio Inc Quarterly Net profit?

Adicet Bio Inc Quarterly Net profit rose 2.58% YoY to $28.73 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

What is Adicet Bio Inc Mutual Fund Holding?

Adicet Bio Inc Mutual Fund Holding increased by 0.35% in the last quarter to 11.75.

What is Adicet Bio Inc Institutional Holding?

Adicet Bio Inc Institutional Holding increased by 0.21% in the last quarter to 72.43.

How is the Adicet Bio Inc today?

The Adicet Bio Inc today is trading in the green, up by 1.32% at 0.77.

How has Adicet Bio Inc performed historically?

The Adicet Bio Inc is currently trading up 1.32% on an intraday basis in the past week the index fell -1.28%. The index has been down -15.38% in the past quarter and fell -64.84% in the past year. You can view this in the overview section.

Adicet Bio Inc XNAS: ACET

Adicet Bio Inc Live Share Price Today, Share Analysis and Chart

Name: Adicet Bio Inc: Is Infosys Ltd. worth buying?
Item: Adicet Bio Inc
Rating: 0.99791675
Author: Trendlyne DVM scores

Download real time

0.77 0.01 (1.32%)

New 52W Low today

186.3K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Adicet Bio Inc Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	63.7
PE TTM Negative PE TTM Unavailable in chosen country	-0.5
Price to Book Low in industry Unavailable in chosen country	0.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	72.4
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	2.6
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	17.9
Piotroski Score Below industry Median Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-24

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

15.2 / 100

Technically Bearish

24.8 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Adicet Bio Inc Stock Price Analysis

Day Price Range 1.3% 1 Day return Unavailable in chosen country	0.8 (LTP) 0.70.8 LowHigh
Week Price Range -1.3% 1 Week return Unavailable in chosen country	0.8 (LTP) 0.70.8 LowHigh
Month Price Range -20.6% 1 Month return Unavailable in chosen country	0.8 (LTP) 0.71 LowHigh
52 Week Price Range -64.8% 1 Year return Unavailable in chosen country	0.8 (LTP) 0.72.4 LowHigh

View full Share Price History

Adicet Bio Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Adicet Bio Inc's Revenue was lower than average estimate 1 time in past 1 year

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Adicet Bio Inc Stock Analysis

Adicet Bio Inc stock analysis with key metrics, changes, and trends.

Adicet Bio Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$117.12 M	17.9%	positive	Annual Net Profit rose 17.9% in the last year to $117.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.
Price to Earning Ratio	-0.54	-	negative	Price to Earning Ratio is -0.54, which is negative.
Stock Price	$0.77	-64.84%	negative	Stock Price fell 64.84% and underperformed its sector by 73.91% in the past year.
Quarterly Net profit	$28.73 M	2.58%	positive	Quarterly Net profit rose 2.58% YoY to $28.73 M. Its sector's average net profit growth YoY for the quarter was -47.3%.
Mutual Fund Holding	11.75 %	0.35%	positive	Mutual Fund Holding increased by 0.35% in the last quarter to 11.75.
Institutional Holding	72.43 %	0.21%	positive	Institutional Holding increased by 0.21% in the last quarter to 72.43.

VIEW LESS

Loading data..

Adicet Bio Inc - Company Profile

What does Adicet Bio Inc do?

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Gross Remuneration

2024

Gross Remuneration

Year

Adicet Bio Inc Live Share Price Today, Share Analysis and Chart

New 52W Low today

Adicet Bio Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Adicet Bio Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Adicet Bio Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Adicet Bio Inc's Revenue was lower than average estimate 1 time in past 1 year

Adicet Bio Inc Stock Analysis

Adicet Bio Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 17.9% in the last year to $117.12 M. Its sector's average net profit growth for the last fiscal year was -32.43%.

Price to Earning Ratio is -0.54, which is negative.

Stock Price fell 64.84% and underperformed its sector by 73.91% in the past year.

Quarterly Net profit rose 2.58% YoY to $28.73 M. Its sector's average net profit growth YoY for the quarter was -47.3%.

Mutual Fund Holding increased by 0.35% in the last quarter to 11.75.

Institutional Holding increased by 0.21% in the last quarter to 72.43.

Adicet Bio Inc - Company Profile

What does Adicet Bio Inc do?

Adicet Bio Inc Management structure

Mr. Chen Schor, M.B.A.

Director, Chief Executive Officer and President

Dr. Donald Healey, PhD

Chief Technology Officer

Dr. Francesco Galimi, M.D.,PhD

Chief Medical Officer

Mr. Nick Harvey

Chief Financial Officer and Principal Accounting Officer

Dr. Blake Aftab, PhD

Chief Scientific Officer

Ms. Julia D. Maltzman

Chief Medical Officer

Adicet Bio Inc Board of directors

Dr. Michael Glen Kauffman, M.D.,PhD

Independent Director

Dr. Lloyd Klickstein, M.D.,PhD

Independent Director

Dr. Carl L. Gordon, C.F.A.,PhD

Independent Director

Mr. Chen Schor, M.B.A.

Director, Chief Executive Officer and President

Mr. Steve Dubin, J.D.

Independent Director

Dr. Aya Jakobovits, PhD

Independent Director

Adicet Bio Inc FAQ

How is Adicet Bio Inc today?

Adicet Bio Inc today is trading in the green, and is up by 1.32% at 0.77.

How has Adicet Bio Inc performed historically?

Adicet Bio Inc is currently trading up 1.32% on an intraday basis. In the past week the stock fell -1.28%. stock has been down -15.38% in the past quarter and fell -64.84% in the past year. You can view this in the overview section.